Vol 3 Chapter 1133: Future Biomedical Technology

Today, a large number of experts from the global biomedical field have gathered at the headquarters of Future Technology Group.
"In the past, I rarely involved medical biotechnology, but among the thousands of laboratories in our group, more than a quarter of the laboratories are dedicated to biomedicine, human health, and microbial genes. In four years, we have devoted thousands of experts and scholars to our group, and finally achieved the first research results in this field."
Facing thousands of experts and scholars from all over the world in the venue, as well as countless media reporters, Cai Ruichen showed his youthful and confident appearance, focused on the flashlight, and said seriously and seriously:
"Precision Medicine Project, a large number of large countries and developing countries in Europe, the United States, Asia, all have conducted a lot of in-depth research in this field, the reason is very simple, everyone in the human body is different, and currently all humans use treatment Medicines for various diseases are all universal. This also makes all medicines suitable for most people. Some people have different physiques. Even though they are the same medicine, they may not work.
This is the reason why countries have begun to carry out precision medicine plans. The starting point for future biomedical technology is similar, but there is one difference. Our research field is specifically aimed at two major medical problems in the world. One is cancer and the other is AIDS.
Take cancer as an example. At present, human medical technology divides cancer into three major categories, namely'small cell carcinoma, squamous cell carcinoma, and adenocarcinoma'. However, this category is of great help to the process of treating cancer. small.
If the patient is suffering from non-small cell carcinoma, the doctor can only choose to use a plan that is less than 10% effective. At the same time, the patient will suffer serious adverse reactions, but if it can pass genomics, proteology, clinical markers, etc. the study. Really prepare the clinical response data at all times, make a more accurate diagnosis for the patient, and then combine the clinical performance. Develop a specific and precise treatment plan, and always evaluate and familiarize with the analysis. Precise adjustment of the treatment plan can control the condition of the patient or alleviate the adverse clinical performance and avoid adverse drug reactions.
Accurate medical technology has brought about a medical innovation, which is recognized globally, and there is no doubt.
In this area of ​​research, we have invested more than four billion US dollars in research funding in four years. As a result, the future hospital will collect all clinical data in these five years. Received human health data from all machine stewards around the world, and established the world's largest human health data center for research.
And here, I need to thank all machine housekeepers in the world and all medical institutions in the world. The data collection work of authorized machine housekeepers has brought great help to our research.
In four years, our biomedical company has not produced any drugs, and only a few sets of more practical auxiliary medical testing equipment are sold in the global medical field.
It is not that we have not been able to produce and develop those ordinary drugs, for those drugs with a cure rate of more than 95%. These are not our goals.
In the future, the research goals of biomedical technology companies are to place drugs with a cure rate of no more than 60%.
Because these areas are global hot medical problems. Including medical problems such as rheumatism and stroke, plus diseases such as cancer and AIDS, combined with big data on human health problems, and through microbial genetic research, it has been found that human beings are the most effective in the field of biomedical treatment for difficult diseases. Practical treatment and detection technology.
I'm afraid not many people know that there are two genomes in the human body, one is a gene inherited from parents. There are only 25,000 genes, these genes are the elite before the baby is born. There is another set of genes that enter the human genome after birth, especially the more than 1,000 kinds of symbiotic microorganisms in the human intestine. The sum of its genetic information is called the microbiome, also known as the metagenome. It contains more than one million genomes, and the health of the human body can only be guaranteed when these two genomes coordinate with each other.
In fact, all diseases in the human body can be found in the metagenome at the early stage or even before their symptoms. "
Speaking of this, Cai Ruichen paused, and looked at the huge science and technology venue, it was all silent, and his serious eyes were all fixed on him.
He slowly continued: "As we all know, the human health scans owned by the machine housekeeper can find information on human diseases in a timely manner. The accuracy rate has reached 99.5%, and this is the group's four years. Today, I will focus on the new key technologies of biomedical technology in the past four years.
The first technology is human safety technology. This technology will also be implemented in the machine housekeeper. The new upgraded version of the machine housekeeper will have the ability to detect cancer cells. After a year of testing, the detection accuracy can be determined to be 100%. Percent.
This detection capability is able to accurately detect the signs of cell canceration before cancer cells appear in the human body, ensuring that the human body is discovered and contained before cancer cells actually appear.
For the specific details, Mr. Lin Zhongxian will give you a detailed introduction at the next machine housekeeper new product launch.
Today, as the first scientific and technological product launch conference of future biomedical technology, we will announce to the world that the probability that cancer will receive complete information ~EbookFREE.me~ is over 95%. "
When Cai Ruichen finally uttered this sentence, the whole venue was suddenly full of turmoil. At present, all countries and biomedical companies in the world have not yet completely treated cancer.
The United States, with the most developed medical treatment, can reduce the mortality rate by 20% at the most while extending the treatment period by five years.
Cancer red blood cells are still one of the biggest problems that plague human health.
Originally, everyone thought this was just a technology show, but the result was far beyond everyone's expectations.
In the venue, a white scholar with white hair sitting in the front row stood up excitedly and asked Cai Ruichen: "Dr. Cai, can you talk about the principle of treatment?"
At this moment, everyone in the venue, including all the shots of the reporter, focused on the scholar, and then turned their eyes on Cai Ruichen, hoping that Cai Ruichen could answer.
The cure rate of cancer drugs is as high as 95%. It will be the biggest medical breakthrough in the 21st century for mankind. (To be continued.)